Affinity Biosciences
Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development.
Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt, AMPK, NF-KappaB, TGF-beta, etc, as well as inhibitors and related reagents:
Among 2000 phospho-specific antibodies, there are exclusive phosphor-specific antibodies (with cat#AF7 and cat#AF8) verified by IHC tissue array and validated with MS report and HPLC report.
Affinity Biosciences is the winner of "Antibody supplier to watch in 2019" awarded by CiteAb:
Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt, AMPK, NF-KappaB, TGF-beta, etc, as well as inhibitors and related reagents:
Among 2000 phospho-specific antibodies, there are exclusive phosphor-specific antibodies (with cat#AF7 and cat#AF8) verified by IHC tissue array and validated with MS report and HPLC report.
Affinity Biosciences is the winner of "Antibody supplier to watch in 2019" awarded by CiteAb:
